Literature DB >> 29956140

Use of the Litomosoides sigmodontis Infection Model of Filariasis to Study Type 2 Immunity.

A Fulton1,2, S A Babayan3, M D Taylor4,5,6.   

Abstract

Helminth parasites infect over 2 billion people worldwide resulting in huge global health and economic burden. Helminths typically stimulate Type 2 immune responses and excel at manipulating or suppressing host-immune responses resulting in chronic infections that can last for years to decades. Alongside the importance for the development of helminth treatments and vaccines, studying helminth immunity has unraveled many fundamental aspects of Type 2 immunity and immune regulation with implications for the treatment of autoimmunity and Type 2-mediated diseases, such as allergies. Here we describe the maintenance and use of Litomosoides sigmodontis, a murine model for studying host-parasite interactions, Type 2 immunity, and vaccines to tissue-dwelling filarial nematodes, which in humans cause lymphatic filariasis (e.g., Brugia malayi) and onchocerciasis (Onchocerca volvulus).

Entities:  

Keywords:  Filariasis; Helminth; Infection model; Parasite; Type 2 immunity

Mesh:

Substances:

Year:  2018        PMID: 29956140     DOI: 10.1007/978-1-4939-7896-0_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections.

Authors:  Malina A Bakowski; Case W McNamara
Journal:  Trop Med Infect Dis       Date:  2019-07-18

2.  Concurrent Infection With the Filarial Helminth Litomosoides sigmodontis Attenuates or Worsens Influenza A Virus Pathogenesis in a Stage-Dependent Manner.

Authors:  Gareth R Hardisty; Johanna A Knipper; Alison Fulton; John Hopkins; Bernadette M Dutia; Matthew D Taylor
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

Review 3.  The immune response of inbred laboratory mice to Litomosoides sigmodontis: A route to discovery in myeloid cell biology.

Authors:  Conor M Finlay; Judith E Allen
Journal:  Parasite Immunol       Date:  2020-03-21       Impact factor: 2.280

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.